Susquehanna International Group, LLP Coherus Bio Sciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$1.58 - $2.51 $61,304 - $97,387	-38,800 Reduced 56.73%	29,600 $51,000
Q1 2024 May 07, 2024	BUY	$2.02 - $3.14 $97,970 - $152,290	48,500 Added 243.72%	68,400 $163,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $152,322 - $368,830	-95,800 Reduced 82.8%	19,900 $66,000
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $309,298 - $450,715	82,700 Added 250.61%	115,700 $432,000
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $125,070 - $273,900	33,000 New	33,000 $140,000
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $199,150 - $352,450	35,000 New	35,000 $277,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $99,603 - $119,636	-6,300 Reduced 37.95%	10,300 $164,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $50,720 - $71,160	-4,000 Reduced 19.42%	16,600 $267,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $77,832 - $89,018	-4,700 Reduced 18.58%	20,600 $358,000
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $31,338 - $35,802	-1,800 Reduced 6.64%	25,300 $464,000
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $591,630 - $785,560	-41,000 Reduced 60.21%	27,100 $484,000
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $273,078 - $527,202	-23,400 Reduced 25.57%	68,100 $1.11 Million
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $231,885 - $303,454	-14,200 Reduced 13.43%	91,500 $1.65 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $1.04 Million - $1.49 Million	63,600 Added 151.07%	105,700 $2.14 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $309,160 - $521,560	23,600 Added 127.57%	42,100 $930,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $1.42 Million - $2.63 Million	-169,800 Reduced 90.18%	18,500 $252,000
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $722,500 - $1.01 Million	50,000 Added 36.15%	188,300 $3.11 Million
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $1 Million - $1.71 Million	98,000 Added 243.18%	138,300 $1.94 Million
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $447,330 - $584,350	40,300	40,300 $538,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$17.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$16.6 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$15.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.46 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.2 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $114M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account